As per attachment

A LKY L Alkyl Amines Chemicals Limited \ ¢ Reg. Office: 401-407, Nirman Vyapar Kendra, Plot No. 10, Sector 17, Vashi, Navi Mumbai - 400 703. INDIA Responsible Care” Tel.: 022-6794 6600 * Fax: 022-6794 6666 * E-mail : alkyl@alkylamines.com * Web: www.alkylamines.com —— pene August 4, 2026 BSE Limited : The National Stock Exchange of India Limited P. J. Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Bandra - (E), Mumbai - 400 001 Mumbai - 400 051 SCRIP CODE: 506767 SYMBOL: ALKYLAMINE Subject: Outcome of Board Meeting held on August 4, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) Dear Sirs, This is to inform you that the Board of Directors of the Company at its meeting held today i.e., August 4, 2026, inter-alia approved the following: 1. Unaudited Financial Results: Unaudited Financial Results of the Company for the quarter ended June 30, 2026, were discussed and approved. We enclose herewith the Unaudited Financial Results of the Company, along with the Auditors’ Limited Review Report thereupon. 2. Re-designation of Directors Based on the recommendation of the Nomination and Remuneration Committee and the Audit Committee, wherever applicable, of the Company and subject to approval of shareholders of the Company through Postal Ballot, the Board has approved the following: a. Re-designation of Mr. Yogesh M. Kothari (DIN: 00010015), Chairman and Managing Director, as the Executive Chairman of the Company under the category of Whole-time Director (Executive Director), with effect from October 1, 2026 up to completion of his existing term on March 31, 2030, on the same terms and conditions of appointment and remuneration as approved by the Members of the Company vide Special Resolution passed through Postal Ballot on September 14, 2024. b. Re-designation of Mr. Kirat M. Patel (DIN: 00019239), Executive Director, as the Joint Managing Director of the Company, with effect from October 1, 2026 up to completion of his existing term on December 31, 2029, on the same terms and conditions of appointment and remuneration as approved by the Members of the Company vide Special Resolution passed through Postal Ballot on September 14, 2024. AL AMS Corporate Office: 207 A, Kakad Chambers, 132, Dr. Annie Besant Road Worli, Mumbai - 400 018. INDIA Tel.: 91-22-2493 1385, 6748 8200 © Fax: 91-22-2493 0710 * CIN No: L99999MH1979PLC021796. ALKYL c. Re-designation of Mr. Suneet Y. Kothari (DIN: 00021421), Executive Director, as the Joint Managing Director of the Company, with effect from October 1, 2026 up to completion of his existing term on December 31, 2029, on the same terms and conditions of appointment and remuneration as approved by the Members of the Company vide Special Resolution passed through Postal Ballot on September 14, 2024. d. Re-designation and appointment of Mr. Rakesh Goyal (DIN: 07977008), Whole-time Director — Operations, as Executive Director - Operations of the Company for a term of five (5) consecutive years from April 1, 2027 to March 31, 2032, on the revised terms and conditions of remuneration. Mr. Yogesh M. Kothari, Mr. Kirat M. Patel, Mr. Suneet Y. Kothari and Mr. Rakesh Goyal are not debarred from holding the office of Director by virtue of any order of SEBI or any other regulatory authority. The requisite details as per Regulation 30 of SEBI Listing Regulations are enclosed. 3. Payment of commission to the Non-Executive Directors of the Company Based on the recommendation of the Nomination and Remuneration Committee of Directors of the Company and subject to approval of shareholders of the Company through Postal Ballot, the Board has approved the payment of Commission to the Non-Executive Director of the Company at a rate not exceeding 1% of the net profits of the Company for a further period of 5 years from the financial year commencing from April 1, 2027. Opening of Trading Window As per the ‘Code of practices and procedures for fair disclosure of Unpublished Price Sensitive Information and Code of conduct for regulating, monitoring and reporting of insider trading’ adopted by the Company and with the announcement of unaudited Financial Results for the quarter ended June 30, 2026, we wish to inform you that the Trading Window for the Designated Persons, Immediate Relatives of Designated Persons and Connected Persons will open from August 7, 2026. The Board Meeting commenced at 12:45 P.M. and concluded at 2:10 P.M. Kindly take the same on your records. Thanking you, For Alkyl Amines Chemicals Limited )o\ Chintamani D. Thatte General Manager (Legal) & Company Secretary & Compliance Officer Encl.: As above. N. M. RAIJI & CO. Chartered Accountants Universal Insurance Building, Pherozeshah Mehta Road, Mumbai - 400 001. INDIA Telephone : 91 (22) 2082 8646 E-mail : nmr.ho@nmraiji.com Independent Auditor's Review Report on the Quarterly Unaudited Financial Results of Alkyl Amines Chemicals Limited, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To The Board of Directors Alkyl Amines Chemicals Limited 1. We have reviewed the accompanying statement of unaudited financial results of Alkyl Amines Chemicals Limited ("the Company"), for the quarter ended June 30, 2026 ("the Statement"), together with the relevant notes thereon, attached herewith, being submitted by the Company, pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations’). 2. This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity’, issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information is limited primarily to inquiries of company personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Companies Act, 2013, and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. We have not performed an audit. Accordingly, we do not express an audit opinion. N.M. RAIJI & CO. 4. Based on our review conducted as stated above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For N. M. Raiji & Co. Chartered Accountants Firm Registration No.: 108296W Vinay D. Balse Partner Membership No.: 039434 UDIN: 260394 34GEQ [Showing first 8,000 characters — download PDF for full document]